Home> Products> controlled release formulation

{ "products": [ { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-09-25T10:46:50.098Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68723260f860f0528a938842", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "AMIPULSIDE CR 400", "description": "AMIPULSIDE CR 400 is a prescription-based, controlled-release formulation of Amisulpride 400 mg, developed to offer sustained therapeutic effects with once-daily dosing. Manufactured to high quality standards, this medication plays a vital role in the management of both acute and chronic schizophrenic disorders. It belongs to the class of atypical antipsychotics and works by regulating the activity of certain neurotransmitters in the brain, primarily dopamine. This helps control symptoms like hallucinations, delusions, disorganized thinking, and social withdrawal associated with schizophrenia.\n\nWhat is AMIPULSIDE CR 400?\nAMIPULSIDE CR 400 contains Amisulpride, a selective dopamine D2/D3 receptor antagonist. It is primarily used in the treatment of schizophrenia, particularly effective in managing both positive symptoms (e.g., hallucinations, delusions) and negative symptoms (e.g., emotional withdrawal, apathy). The controlled-release (CR) formulation allows for steady absorption and action, improving patient compliance and reducing fluctuations in symptom control.\n\nThis medication is designed for the treatment of acute and chronic schizophrenic disorders and is often used as part of a comprehensive psychiatric care plan, including counseling and behavioral therapy.\n\nUses of AMIPULSIDE CR 400\nManagement of acute episodes of schizophrenia\n\nLong-term maintenance therapy for chronic schizophrenic disorders\n\nEffective in treating positive symptoms (e.g., hallucinations, paranoia)\n\nBeneficial in alleviating negative symptoms (e.g., lack of motivation, social withdrawal)\n\nSide Effects of AMIPULSIDE CR 400\nLike all medications, AMIPULSIDE CR 400 may cause side effects in some patients. Common side effects include:\n\nInsomnia or drowsiness\n\nWeight gain\n\nConstipation\n\nAnxiety\n\nIncreased prolactin levels (can lead to breast tenderness or menstrual changes)\n\nTremors or stiffness (extrapyramidal symptoms)\n\nSerious but rare side effects may include:\n\nNeuroleptic malignant syndrome (fever, muscle rigidity, confusion)\n\nIrregular heart rhythms\n\nSeizures\n\nSeek immediate medical help if you experience chest pain, severe dizziness, or signs of an allergic reaction.\n\nPrecautions Before Using AMIPULSIDE CR 400\nBefore starting treatment with AMIPULSIDE CR 400, inform your doctor if:\n\nYou have a history of heart disease or irregular heart rhythms\n\nYou suffer from kidney or liver dysfunction\n\nYou are pregnant, planning pregnancy, or breastfeeding\n\nYou have Parkinson’s disease\n\nYou have low potassium or magnesium levels in your blood\n\nAvoid alcohol and other central nervous system depressants while taking this medication, as they may increase drowsiness or impair alertness.\n\nDrug Interactions\nAmisulpride can interact with a variety of medications, which may enhance or diminish its therapeutic effects or increase the risk of adverse events.\n\nWhat Drugs Interact with AMIPULSIDE CR 400?\nAntiarrhythmic drugs (e.g., quinidine, amiodarone): May increase the risk of heart rhythm abnormalities\n\nCNS depressants (e.g., benzodiazepines, opioids): Increase sedation and respiratory depression risk\n\nLevodopa and dopamine agonists: Can counteract the effect of Amisulpride\n\nSSRIs (e.g., fluoxetine, paroxetine): May increase the plasma levels of Amisulpride\n\nDrugs that prolong QT interval (e.g., erythromycin, haloperidol): May raise the risk of cardiac arrhythmias\n\nDiuretics: May alter electrolyte balance, increasing risk of heart rhythm disturbances\n\nAlways disclose all medications, supplements, or herbal products you are taking to your healthcare provider before starting AMIPULSIDE CR 400.\n\nConclusion\n\nAMIPULSIDE CR 400 (Amisulpride 400 mg CR Tablet) is a clinically effective medication for individuals suffering from schizophrenia, offering reliable symptom control through its controlled-release formulation. Its ability to treat both the acute and chronic phases of the disorder makes it a cornerstone in psychiatric management. Regular monitoring and adherence to prescribed guidelines ensure optimal results and improved quality of life for patients.", "price": 595.0, "discountamount": 179.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2145, "imageuri": "https://productimages.withfloats.com/actual/687232764d22e47aa874e361.png", "tileimageuri": "https://productimages.withfloats.com/tile/687232764d22e47aa874e361.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-12T10:01:04.938Z", "updatedon": "2025-07-12T10:01:04.938Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/amipulside-cr-400/2145", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "amisulpride tablet", "category": "NEUROLOGY RANGE", "tags": [ "Amisulpride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67fe35b95f647a4e69892276", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ivabradine Controlled Release (10mg)", "description": "Ivabradine is used in the treatment and management of chronic heart failure and stable angina through the controlled release formulation in IVADINE CR 10, what helps control the heart rate. It assists in increasing the efficacy of the heart and the general well-being of the patients suffering from cardiovascular diseases by controlling the heart rate.\n\nImportant Ingredients:\n\nThe major bod of ivabradine also known as active constituent is ionically bound to a polymedic excipient, so controlled release medicament form retains the participant to ensure vying therapeutic result while sidestepping untoward consequences.\n\nMajor Advantages:\n\nHeart Rate Control: IVADINE CR 10 allows the heart to beat without putting pressure resulting in better pumping of blood, furthermore, it makes it easier to IVADINE CR 10 protects the heart rate from extreme spikes. Reduces heart rate.\n\nSymptom Relief: Chest pain or estrapade is eased, relieved and helped much in congruency heart failure. Also, it aids in relieving pain due to angina and lack of breath.\n\nEnhanced Exercise Tolerance: Greater capacity is observed in scope, patients physical activity also improves.\n\nBetter Quality of Life: It helps well being and well help ad in lesser use of hospitalization due the patient surpasses restrictions posed by heart failure.How Does It Work?\n\nThe ‘funny’ (If) channel in the sinoatrial node or the natural heart pacemaker gets selectively inhibited by Ivabradine which prevents the progression of angina and heart failure symptoms in the patients. This is possible with the use of IVADINE CR 10, as it reduces the myocardial oxygen demand by slowing down the heart rate.\n\nDirections for Use:\n\nDosage: The medication must be taken as per the recommendation of the physician. Generally, the prescription is a single tablet to be taken once a day.\n\nAdministration: The capsule is to be taken in its entirety without crushing or chewing it and is to be followed with a glass of water.\n\nTiming: The tablet can be taken both with and without the food, but make sure that the dosage is taken at the same time in every 24 hour period so that the optimal balance of the medicine is maintained in the body.\n\nSide Effects:\n\nCommon Side Effects: Bradycardia (body going into the slow heart rate phase), headaches, dizziness and seeing bright spots which can be classified as visual disturbances.\n\nSerious Side Effects: Atrial fibrillation or severe bradycardia and heart block. Any dire side effects should be reported immediately.\n\nSafety Information:\n\nContraindications: Markedly unsuitable for patients inflicted with advanced liver damage, bradycardic condition or acute heart failure.\n\nPregnancy and Breastfeeding: Do check with your physician if you are already pregnant, intending to get pregnant or is in the phase of breastfeeding.\n\nSociodramatic Work: Update your physician on any other medications and interventions which you are taking, as Ivabradine has the possibility of interacting with other heart or blood pressure medication.\n\nOperating Vehicles or Machinery: Given Ivabradine may cause problems with vision and dizziness, refrain from driving and heavy machinery if you have symptoms of these.\n\nRoutine Checkup: Routine check with your physician’s appointment helps assure follow up on the heart rate, if the dosage change is indicated, it shall be adjusted.\n", "price": 329.0, "discountamount": 99.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "dosage change", "physician generally", "stable angina", "heavy machinery", "pregnant intending", "single tablet", "helps control", "patients inflicted", "patients suffering", "dizziness refrain", "severe bradycardia", "visual disturbances", "bright spots", "optimal balance", "24 hour period", "water timing", "day administration", "selectively inhibited", "sinoatrial node", "eased relieved", "polymedic excipient", "ionically bound", "active constituent", "major bod", "cardiovascular diseases", "general wellbeing", "ivadine cr 10", "heart block", "heart failurehow", "heart rate", "hospitalization due", "heart failure symptoms", "heart rate directions", "natural heart pacemaker", "congruency heart failure", "chronic heart failure", "relieving pain due", "dire side effects", "myocardial oxygen demand", "putting pressure resulting", "controlled release formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2083, "imageuri": "https://productimages.withfloats.com/actual/67fe35bbfd15513fb8533317.png", "tileimageuri": "https://productimages.withfloats.com/tile/67fe35bbfd15513fb8533317.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-15T10:32:25.313Z", "updatedon": "2025-04-15T10:33:44.06Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ivabradine-controlled-release-10mg-/2083", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IVADINE CR 10", "category": "CARDIOLOGYRANGE", "tags": [ "Ivabradine 10 mg", "Ivabradine 10 mg price in India", "Ivabradine mechanism of action" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6790bd2262059c5632ce4d2d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Magnesium Valproate 200mg", "description": "VALPOTREAT MAG 200 is a specially formulated medication containing Magnesium Valproate in a controlled-release tablet. It is widely prescribed to manage and control various neurological conditions such as epilepsy and bipolar disorder. Designed for effective absorption and consistent therapeutic effects, this medication helps stabilize mood and prevent seizures, improving the quality of life for those dealing with these conditions.\n\n \nKey Benefits:\n \n\nSeizure Control: Effective in preventing and managing various types of seizures, including absence seizures, generalized tonic-clonic seizures, and complex partial seizures.\nMood Stabilization: Provides relief from mood swings and supports emotional balance in patients with bipolar disorder.\nControlled Release: Ensures gradual absorption, reducing fluctuations in drug levels and minimizing side effects.\nNeurological Support: Enhances brain health and stabilizes nerve impulses, making it an essential treatment for epilepsy and related conditions.\nBetter Tolerability: The addition of magnesium reduces gastrointestinal discomfort, often associated with other valproate formulations.\n \nHow Does It Work?\n \n\nMagnesium Valproate works by increasing the availability of gamma-aminobutyric acid (GABA), a neurotransmitter in the brain that calms nerve activity. By stabilizing neuronal firing, it prevents excessive electrical discharges that lead to seizures. Additionally, it balances neurotransmitters involved in mood regulation, making it effective for managing bipolar disorder. The controlled-release formulation ensures consistent drug levels, offering prolonged symptom control while minimizing side effects.\n\n \nDirections for Use:\n \n\nDosage: Take the dose as prescribed by your healthcare provider, usually once or twice daily.\nWith Food: To minimize gastrointestinal irritation, take the tablet with or after meals.\nSwallow Whole: Do not crush or chew the tablet to preserve the controlled-release properties.\nConsistency: Take the medication at the same time each day for optimal effectiveness.\nMissed Dose: If a dose is missed, take it as soon as you remember. Skip the missed dose if it’s close to the next scheduled dose.\n \nSide Effects:\n \n\nWhile VALPOTREAT MAG 200 is generally well-tolerated, some individuals may experience mild to moderate side effects, including:\n\nCommon Side Effects: Nausea, vomiting, dizziness, drowsiness, and abdominal discomfort.\nRare Side Effects: Tremors, weight changes, hair loss, and temporary changes in liver enzyme levels.\nSevere Reactions: In rare cases, severe allergic reactions, unusual bleeding, or behavioral changes may occur. If these symptoms arise, seek immediate medical attention.", "price": 78.0, "discountamount": 24.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "missed dose", "effective absorption", "widely prescribed", "controlledrelease tablet", "medical attention", "hair loss", "experience mild", "generally welltolerated", "valpotreat mag 200", "remember skip", "meals swallow", "healthcare provider", "seizures additionally", "valproate formulations", "related conditions", "essential treatment", "drug levels", "neurological conditions", "magnesium valproate", "mood swings", "managing bipolar disorder", "prevent seizures improving", "specially formulated medication", "controlledrelease properties consistency", "mood regulation making", "symptoms arise seek", "moderate side effects", "minimize gastrointestinal irritation", "balances neurotransmitters involved", "stabilizing neuronal firing", "calms nerve activity", "gammaaminobutyric acid gaba", "supports emotional balance", "consistent therapeutic effects", "bipolar disorder designed" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2035, "imageuri": "https://productimages.withfloats.com/actual/6790bd322323937ff0a17443.png", "tileimageuri": "https://productimages.withfloats.com/tile/6790bd322323937ff0a17443.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-01-22T09:40:50.336Z", "updatedon": "2025-01-22T09:40:50.336Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magnesium-valproate-200mg/2035", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT MAG 200 ", "category": "neurology", "tags": [ "Magnesium valproate vs sodium valproate", "Magnesium valproate prolonged release tablets", "Magnesium valproate Wikipedia", "Magnesium valproate side effects", "Magnesium valproate Brand Name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e7ff07e47881008f6860e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRIMETAZ CR 80 ", "description": "TRIMETAZ CR 80 \nTrimetazidine (80mg)\nIntroduction\nTRIMETAZ CR 80 is a medication containing Trimetazidine hydrochloride, formulated to treat angina pectoris and certain other cardiovascular conditions. It is known for its metabolic effects on the heart muscle, improving myocardial efficiency and reducing symptoms associated with ischemic heart disease.\n\nComposition\n\nTrimetazidine (80mg): The active ingredient, Trimetazidine, acts as a cellular metabolic agent that enhances myocardial glucose utilization and improves energy production in the heart muscle.\nMechanism of Action\nTrimetazidine exerts its therapeutic effects through several mechanisms:\n\nMetabolic Regulation: Shifts myocardial energy substrate utilization from fatty acids toward glucose oxidation, which is more efficient and requires less oxygen.\nAnti-ischemic Effect: Protects the heart against ischemic damage by preserving cellular energy metabolism and reducing oxidative stress.\nImprovement in Symptomatology: Reduces angina symptoms such as chest pain, shortness of breath, and exercise intolerance by enhancing myocardial function.\nIndications\nTRIMETAZ CR 80 is indicated for:\n\nChronic Stable Angina Pectoris: Used as adjunctive therapy in patients who are inadequately controlled with other anti-anginal medications.\nIschemic Heart Disease: Helps improve myocardial function and reduce symptoms associated with coronary artery disease.\nDosage and Administration\n\nThe usual dosage of TRIMETAZ CR 80 is one tablet (80mg) taken orally twice daily, preferably with meals.\nThe extended-release formulation ensures sustained therapeutic levels of Trimetazidine throughout the day.\nDosage adjustments may be necessary based on individual patient response and tolerance.\nSide Effects\nCommon side effects may include:\n\nHeadache\nDizziness\nNausea\nGastrointestinal disturbances (such as abdominal pain or diarrhea)\nSevere side effects are rare but may include:\n\nAllergic reactions (rash, itching, swelling)\nExtrapyramidal symptoms (involuntary movements)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with severe renal impairment or hepatic dysfunction, as Trimetazidine metabolism may be altered.\nMonitor patients for signs of extrapyramidal symptoms, especially in patients with Parkinson's disease or other movement disorders.\nAvoid abrupt discontinuation of Trimetazidine, as it may worsen angina symptoms.\nDrug Interactions\n\nTrimetazidine may interact with other medications that affect myocardial metabolism or cardiac function, including beta-blockers and calcium channel blockers. Close monitoring is recommended when used concomitantly.\nConclusion\nTRIMETAZ CR 80 is a valuable therapeutic option for managing chronic stable angina pectoris and ischemic heart disease by improving myocardial efficiency and reducing symptoms associated with cardiac ischemia. Its mechanism of action, focusing on metabolic modulation and anti-ischemic effects, makes it an effective adjunctive therapy in patients with inadequate symptom control on standard anti-anginal medications. Proper dosage, administration, and monitoring for side effects are essential to ensure safe and effective use of TRIMETAZ CR 80 in cardiovascular patients. Consultation with a healthcare provider is recommended for personalized treatment plans and management of cardiac conditions with TRIMETAZ CR 80.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 435.0, "discountamount": 130.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one tablet", "chest pain", "less oxygen", "fatty acids", "TRIMETAZ CR", "usual dosage", "heart muscle", "Proper dosage", "effective use", "abdominal pain", "angina symptoms", "ischemic damage", "Close monitoring", "cardiac ischemia", "oxidative stress", "cardiac function", "Drug Interactions", "active ingredient", "glucose oxidation", "metabolic effects", "energy production", "other medications", "Dosage adjustments", "Allergic reactions", "adjunctive therapy", "several mechanisms", "cardiac conditions", "healthcare provider", "Hepatic dysfunction", "myocardial function", "therapeutic effects", "Severe side effects", "Common side effects", "metabolic modulation", "Metabolic Regulation", "liver function tests", "involuntary movements", "anti-ischemic effects", "myocardial efficiency", "myocardial metabolism", "abrupt discontinuation", "ischemic heart disease", "Extrapyramidal symptoms", "cardiovascular patients", "coronary artery disease", "severe renal impairment", "Trimetazidine metabolism", "cellular metabolic agent", "other movement disorders", "calcium channel blockers", "cellular energy metabolism", "inadequate symptom control", "Trimetazidine hydrochloride", "valuable therapeutic option", "individual patient response", "extended-release formulation", "sustained therapeutic levels", "personalized treatment plans", "Gastrointestinal disturbances", "other anti-anginal medications", "myocardial glucose utilization", "Chronic Stable Angina Pectoris", "other cardiovascular conditions", "standard anti-anginal medications", "myocardial energy substrate utilization" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1938, "imageuri": "https://productimages.withfloats.com/actual/668e7ff3f07c99c3af8e8504.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e7ff3f07c99c3af8e8504.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:34:56.538Z", "updatedon": "2024-07-10T12:34:56.538Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trimetaz-cr-80-/1938", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TRIMETAZ CR 80 ", "category": "CARDIOLOGYRANGE", "tags": [ "Trimetazidine 80mg price", "Trimetazidine 35 mg uses", "Trimetazidine 80 mg brand name", "When to stop taking trimetazidine", "Trimetazidine hydrochloride extended release CAPSU", "Trimetazidine mechanism of action", "Trimetazidine 35 mg brand name", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "668e77e853fc1c2298508399", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD PIO 20/15 ", "description": "TENELIGOLD PIO 20/15 \nTeneligliptin & Pioglitazone\nIntroduction\nTENELIGOLD PIO 20/15 combines two antidiabetic medications, Teneligliptin and Pioglitazone, in a single formulation. This combination is designed to manage type 2 diabetes mellitus by targeting different aspects of glucose metabolism, thereby improving glycemic control in patients who are inadequately controlled with monotherapy or require dual therapy.\n\nComposition\n\nTeneligliptin: A dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and reduces glucagon release, thereby lowering blood glucose levels.\nPioglitazone: A thiazolidinedione (TZD) that improves insulin sensitivity in peripheral tissues (muscle and adipose tissue) and reduces hepatic glucose production.\nMechanism of Action\n\nTeneligliptin: Inhibits the degradation of incretin hormones (GLP-1 and GIP), which play a key role in glucose-dependent insulin secretion and suppression of glucagon secretion.\nPioglitazone: Activates peroxisome proliferator-activated receptor gamma (PPAR-γ), leading to improved insulin sensitivity, enhanced glucose uptake in peripheral tissues, and reduced hepatic glucose production.\nIndications\nTENELIGOLD PIO 20/15 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults who are inadequately controlled with diet and exercise alone or with other antidiabetic medications.\nDosage and Administration\n\nThe typical dosage is one tablet of TENELIGOLD PIO 20/15 taken orally once daily, preferably with meals.\nDosage adjustments may be necessary based on individual patient response and tolerability.\nIt is important to adhere to the prescribed dosage regimen to achieve optimal glycemic control.\nSide Effects\nCommon side effects may include:\n\nHypoglycemia (especially when used in combination with insulin or sulfonylureas)\nEdema (fluid retention)\nWeight gain\nHeadache\nNasopharyngitis (common cold)\nMore severe side effects can include:\n\nHeart failure (especially in patients with pre-existing cardiovascular disease)\nHepatic dysfunction (monitor liver function tests periodically)\nBone fractures (especially in women)\nPrecautions\n\nHeart Failure: Use with caution in patients with a history of heart failure or other cardiovascular diseases.\nBladder Cancer: Pioglitazone has been associated with an increased risk of bladder cancer; therefore, it should be used cautiously in patients with a history of bladder cancer or with risk factors.\nLiver Function: Monitor liver function tests before starting treatment and periodically thereafter, as Pioglitazone may cause hepatic dysfunction.\nPregnancy and Lactation: Use during pregnancy and lactation should be avoided unless the potential benefits outweigh the risks.\nDrug Interactions\n\nInsulin/Sulfonylureas: Increased risk of hypoglycemia when used concomitantly with insulin or sulfonylureas.\nGemfibrozil: May increase Pioglitazone levels, requiring dose adjustment.\nCYP2C8 Inhibitors (e.g., Gemfibrozil): May increase Pioglitazone concentrations, necessitating monitoring for adverse effects.\nConclusion\nTENELIGOLD PIO 20/15 offers a dual-action approach to managing type 2 diabetes mellitus by combining Teneligliptin and Pioglitazone. This combination helps improve glycemic control through different mechanisms: enhancing insulin secretion and sensitivity. It is crucial to use this medication under the guidance of a healthcare professional to optimize treatment outcomes while minimizing the risk of side effects. Regular monitoring for efficacy and safety parameters, including blood glucose levels and potential adverse effects, is essential for managing diabetes effectively with TENELIGOLD PIO 20/15.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n\n", "price": 149.0, "discountamount": 44.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "key role", "one tablet", "Weight gain", "common cold", "risk factors", "dual therapy", "Heart failure", "increased risk", "dosage regimen", "typical dosage", "Bladder Cancer", "Bone fractures", "adipose tissue", "TENELIGOLD PIO", "glucose uptake", "dose adjustment", "fluid retention", "glucagon release", "DPP-4) inhibitor", "safety parameters", "CYP2C8 Inhibitors", "Drug Interactions", "incretin hormones", "different aspects", "Regular monitoring", "treatment outcomes", "Dosage adjustments", "peripheral tissues", "single formulation", "glucagon secretion", "potential benefits", "glucose metabolism", "insulin sensitivity", "Pioglitazone levels", "Hepatic dysfunction", "Common side effects", "different mechanisms", "dual-action approach", "liver function tests", "blood glucose levels", "dipeptidyl peptidase-4", "healthcare professional", "optimal glycemic control", "type 2 diabetes mellitus", "More severe side effects", "potential adverse effects", "hepatic glucose production", "Pioglitazone concentrations", "individual patient response", "two antidiabetic medications", "other cardiovascular diseases", "other antidiabetic medications", "existing cardiovascular disease", "glucose-dependent insulin secretion", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1935, "imageuri": "https://productimages.withfloats.com/actual/668e77ebf07c99c3af8e6d67.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/668e77ebf07c99c3af8e6d67.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-07-10T12:00:40.528Z", "updatedon": "2024-07-10T12:00:40.528Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-pio-20-15-/1935", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD PIO 20/15 ", "category": "DIABETIC RANGE", "tags": [ "teneligliptin + pioglitazone brand name", "Zita Plus Pio", "Teneligliptin + Pioglitazone Metformin", "Zita Piomet 1000", "Teneligliptin 20 MG and Pioglitazone 15 MG tablets", "Dapagliflozin", "Zita Piomet 500" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c1007162db0236048bac5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 500 ", "description": "VALPOTREAT CR 500 \nSodium Valproate CR 500 mg\nIntroduction:\n\nVALPOTREAT CR 500 contains Sodium Valproate, a potent anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 500mg, VALPOTREAT CR 500 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 500 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 500 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 500 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 500 for adults typically starts at 500mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 500mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 500 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 500 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/valpotreat-cr-500-134217", "price": 121.18, "discountamount": 36.35, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "food", "time", "need", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "epilepsy", "severity", "patients", "Benefits", "frequency", "two doses", "adherence", "medication", "mood swings", "information", "initial dose", "GABA) levels", "tolerability", "sterispharma", "Key Features", "Introduction", "sterisonline", "various types", "CALL/WHATSAPP", "liver function", "Initial Dosage", "patient safety", "overall health", "manic episodes", "steady release", "mood stability", "mood stabilizer", "symptom control", "frequent dosing", "dosage strength", "seizure episodes", "absence seizures", "bipolar disorder", "treatment regimen", "clinical response", "neuronal activity", "Mood Stabilization", "Regular monitoring", "Sodium Valproate CR", "Continued Monitoring", "long-term management", "therapeutic efficacy", "Anticonvulsant Action", "potent anticonvulsant", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "favorable safety profile", "complex partial seizures", "typical maintenance dose", "VALPOTREAT CR 500 therapy", "VALPOTREAT CR 500 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1909, "imageuri": "https://productimages.withfloats.com/actual/666c100b8c6c791fd3b72fe4.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c100b8c6c791fd3b72fe4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:40:23.921Z", "updatedon": "2024-06-26T05:53:21.154Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-500-/1909", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 500 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 500 mg", "VALPOTREAT CR 500", "", "VALPOTREAT CR 500 price", "", "valprol cr 500 uses and side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c0efb162db0236048ba8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 300 ", "description": "VALPOTREAT CR 300 \nSodium Valproate CR 300 mg\nIntroduction:\n\nVALPOTREAT CR 300 contains Sodium Valproate, a highly effective anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 300mg, VALPOTREAT CR 300 is designed to provide sustained therapeutic effects for managing epilepsy and bipolar disorder, significantly enhancing the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 300 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It increases gamma-aminobutyric acid (GABA) levels in the brain, helping stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer for treating bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 300 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This leads to better symptom control and improved adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 300 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 300 for adults typically starts at 300-600mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 300-600mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 300 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 300 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/valpotreat-cr-300-134219", "price": 78.0, "discountamount": 23.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "life", "time", "food", "need", "EMAIL", "brain", "water", "adults", "option", "quality", "patients", "Benefits", "severity", "epilepsy", "adherence", "two doses", "frequency", "medication", "information", "mood swings", "Introduction", "initial dose", "sterisonline", "sterispharma", "tolerability", "GABA) levels", "Key Features", "various types", "CALL/WHATSAPP", "overall health", "Initial Dosage", "patient safety", "mood stability", "manic episodes", "steady release", "liver function", "mood stabilizer", "dosage strength", "symptom control", "frequent dosing", "bipolar disorder", "absence seizures", "seizure episodes", "neuronal activity", "treatment regimen", "clinical response", "Regular monitoring", "Mood Stabilization", "Sodium Valproate CR", "long-term management", "therapeutic efficacy", "Continued Monitoring", "Anticonvulsant Action", "usual maintenance dose", "gamma-aminobutyric acid", "consistent blood levels", "effective anticonvulsant", "complex partial seizures", "typical maintenance dose", "favorable safety profile", "VALPOTREAT CR 300 therapy", "VALPOTREAT CR 300 tablets", "Administration Instructions", "gastrointestinal discomfort", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1908, "imageuri": "https://productimages.withfloats.com/actual/666c0efef068be46bdec91c1.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c0efef068be46bdec91c1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:35:55.629Z", "updatedon": "2024-06-29T12:22:31.565Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-300-/1908", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 300 ", "category": "NEUROLOGY RANGE", "tags": [ "Sodium Valproate CR 300 mg", "VALPOTREAT CR 300", "", "VALPOTREAT CR 300", "valprol cr 300 side effects", "valprol cr 300 generic name", "valprol cr 300 dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c0dc4a20cb421407442bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VALPOTREAT CR 200 ", "description": "VALPOTREAT CR 200 \nSodium Valproate CR 200 mg\nIntroduction:\n\nVALPOTREAT CR 200 contains Sodium Valproate, a widely used anticonvulsant and mood stabilizer, in a controlled-release (CR) formulation. With a dosage strength of 200mg, VALPOTREAT CR 200 is designed to provide sustained therapeutic effects for the management of epilepsy and bipolar disorder, improving the quality of life for patients.\nKey Features and Benefits:\n\nAnticonvulsant Action:\n\nVALPOTREAT CR 200 is highly effective in treating various types of seizures, including generalized tonic-clonic seizures, absence seizures, and complex partial seizures. It works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, which helps stabilize neuronal activity and prevent seizure episodes.\nMood Stabilization:\n\nSodium Valproate is also used as a mood stabilizer in the treatment of bipolar disorder. It helps control manic episodes and provides mood stability, reducing the frequency and severity of mood swings.\nControlled-Release Formulation:\n\nThe controlled-release formulation of VALPOTREAT CR 200 ensures a steady release of the medication over time, maintaining consistent blood levels and reducing the need for frequent dosing. This helps in achieving better symptom control and improving adherence to the treatment regimen.\nWell-Tolerated and Safe:\n\nVALPOTREAT CR 200 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of epilepsy and bipolar disorder.\nDosage and Administration:\n\nInitial Dosage for Epilepsy:\n\nThe initial dose of VALPOTREAT CR 200 for adults typically starts at 200-400mg per day, divided into two doses. The dose can be gradually increased based on the patient's response and tolerability, with a usual maintenance dose ranging from 1000-2000mg per day.\nInitial Dosage for Bipolar Disorder:\n\nFor the treatment of bipolar disorder, the initial dose usually starts at 200-400mg per day, divided into two doses. The dose can be gradually increased based on clinical response, with a typical maintenance dose ranging from 1000-1500mg per day.\nAdministration Instructions:\n\nVALPOTREAT CR 200 tablets should be taken orally with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of blood levels, liver function, and overall health is essential during VALPOTREAT CR 200 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/valpotreat-cr-200-134218", "price": 75.0, "discountamount": 22.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "need", "life", "GABA", "food", "time", "EMAIL", "water", "brain", "adults", "option", "product", "quality", "severity", "epilepsy", "Benefits", "patients", "adherence", "frequency", "two doses", "medication", "information", "mood swings", "Introduction", "initial dose", "Key Features", "tolerability", "sterispharma", "sterisonline", "CALL/WHATSAPP", "various types", "patient safety", "Initial Dosage", "overall health", "steady release", "liver function", "mood stability", "manic episodes", "dosage strength", "mood stabilizer", "symptom control", "frequent dosing", "absence seizures", "bipolar disorder", "seizure episodes", "clinical response", "treatment regimen", "neuronal activity", "Regular monitoring", "Mood Stabilization", "Sodium Valproate CR", "therapeutic efficacy", "long-term management", "Continued Monitoring", "Anticonvulsant Action", "usual maintenance dose", "consistent blood levels", "gamma-aminobutyric acid", "typical maintenance dose", "complex partial seizures", "favorable safety profile", "VALPOTREAT CR 200 therapy", "VALPOTREAT CR 200 tablets", "gastrointestinal discomfort", "Administration Instructions", "sustained therapeutic effects", "Controlled-Release Formulation", "generalized tonic-clonic seizures", "controlled-release (CR) formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1907, "imageuri": "https://productimages.withfloats.com/actual/666c0dc8c9162f54a15a020e.png", "tileimageuri": "https://productimages.withfloats.com/tile/666c0dc8c9162f54a15a020e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:30:44.587Z", "updatedon": "2024-06-26T09:16:37.475Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/valpotreat-cr-200-/1907", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VALPOTREAT CR 200 ", "category": "NEUROLOGY RANGE", "tags": [ "VALPOTREAT CR 200", "Sodium Valproate CR 200 mg", "valpotreat cr 200 uses in hindi", "valprol cr 200 uses in hindi", "valpotreat cr 200 expiry date", "valpotreat" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }